Summit Therapeutics, Inc. (SMMT)
14.40
+0.78
(+5.73%)
USD |
NASDAQ |
Sep 01, 15:15
Summit Therapeutics Net Income (TTM) : -856.09M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -856.09M |
| March 31, 2026 | -1.206B |
| December 31, 2025 | -1.080B |
| September 30, 2025 | -921.61M |
| June 30, 2025 | -746.08M |
| March 31, 2025 | -240.75M |
| December 31, 2024 | -221.31M |
| September 30, 2024 | -196.71M |
| June 30, 2024 | -161.73M |
| March 31, 2024 | -116.06M |
| December 31, 2023 | -614.96M |
| September 30, 2023 | -597.59M |
| June 30, 2023 | -597.71M |
| March 31, 2023 | -599.76M |
| December 31, 2022 | -78.78M |
| September 30, 2022 | -86.65M |
| June 30, 2022 | -84.87M |
| March 31, 2022 | -92.51M |
| December 31, 2021 | -88.60M |
| September 30, 2021 | -75.04M |
| June 30, 2021 | -73.19M |
| March 31, 2021 | -64.05M |
| Date | Value |
|---|---|
| December 31, 2020 | -52.87M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | 10.08M |
| October 31, 2018 | 1.489M |
| July 31, 2018 | 10.91M |
| April 30, 2018 | -28.76M |
| January 31, 2018 | -26.52M |
| October 31, 2017 | -17.43M |
| July 31, 2017 | -22.19M |
| April 30, 2017 | -26.92M |
| January 31, 2017 | -28.74M |
| October 31, 2016 | -30.09M |
| July 31, 2016 | -31.38M |
| April 30, 2016 | -28.67M |
| January 31, 2016 | -25.99M |
| October 31, 2015 | -23.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| NovelStem International Corp. | -0.3076M |
| Brainstorm Cell Therapeutics, Inc. | -10.52M |
| Kezar Life Sciences, Inc. | -45.23M |
| Protara Therapeutics, Inc. | -70.02M |
| Clene, Inc. | -39.52M |